RxDoctor Payments Data

Rayshunale Smith, APRN

Nurse Practitioner · Louisville, KYNPI 1639420276

Payments from drug & device makers

$2,499in general payments, 2019–2025

Across 36 payments — averaging $69.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$777
  • Philips North America LLC$301
  • Bayer$232
  • AbbVie$210
  • Abiomed$143
  • GSK$125
  • plus $712 from 9 others

What the payments were for

  • Food & beverage$2,499100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,499 in reported general payments places this provider in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$107,502
Medicare patients
305
Services billed
1,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$34,296
BrilintaTicagrelor23$13,491
XareltoRivaroxaban22$6,437
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen180$1,944
Pregabalin19$1,685
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$1,595
Gabapentin120$1,252
Midodrine Hcl24$1,206
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$1,031
Pentoxifylline22$558
Baclofen19$469
ClopidogrelClopidogrel Bisulfate52$436
Amiodarone Hcl29$335
Lorazepam28$287
Hydralazine Hcl28$282

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$121$13,49123 claims
Johnson & JohnsonXarelto$777$6,43722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →